Bronchopulmonary segmental lavage with surfaxin (KL4-surfactant) for acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 4, 1999, Pages 1188-1195

  Wiswell, Thomas E ^{a,b,c,d,e,f,g,h}   Smith, Robert M ^{a,b,c,d,e,f,g}   Katz, Laurence B ^{a,b,c,d,e,f,g}   Mastroianni, Lisa ^{a,b,c,d,e,f,g}   Wong, Davies Y ^{a,b,c,d,e,f,g}   Willms, David ^{a,b,c,d,e,f,g}   Heard, Stephen ^{a,b,c,d,e,f,g}   Wilson, Mark ^{a,b,c,d,e,f,g}   Hite, R Duncan ^{a,b,c,d,e,f,g}   Anzueto, Antonio ^{a,b,c,d,e,f,g}   Revak, Susan D ^{a,b,c,d,e,f,g}   Cochrane, Charles G ^{a,b,c,d,e,f,g}  

^a Discovery Laboratories Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHARP MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

^h Discovery Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT;

ADULT; AGED; ARTICLE; BRONCHOSCOPE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; LUNG LAVAGE; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RISK ASSESSMENT; SUCTION;

EID: 0032831193     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.4.9808118     Document Type: Article

References (31)

1. Brandstetter, R. D., K. C. Sharma, M. DellaBadia, L. J. Cabreros, and G. S. Kabinoff. 1997. Adult respiratory distress syndrome: a disorder in need of improved outcome. Heart Lung 26:3-14.
2. Wiedemann, H. P., and D. Y. Tai. 1997. Adult respiratory distress syndrome (ARDS): current management, future directions. Cleveland Clin. J. Med. 64:365-372.
3. Fulkerson, W. J., N. Maclntyre, J. Stamler, and J. D. Crapo. 1996. Pathogenesis und treatment of the adult respiratory distress syndrome. Arch. Intern. Med. 156:29-38.
4. Schuster, D. P., and M. H. Kollef. 1996. Acute respiratory distress syndrome. Dis. Month 42:267-326.
5. Schuster, D. P., and M. H. Kollef. 1995. The acute respiratory distress syndrome. N. Engl. J. Med. 332:27-37.
6. Sachdeva, R. C., and K. K. Guntupalli. 1997. Acute respiratory distress syndrome. Crit. Care Clin. 13:503-521.
7. Nicholas, T. E., I. R. Doyle, and A. D. Bersten. 1997. Surfactant replacement therapy in ARDS: white knight or noise in the system? Thorax 52:195-197.
8. Jobe, A, H., and M. Ikegami. 1997. Surfactant for acute respiratory distress syndrome. Adv. Intern. Med. 42:203-230.
9. Revak, S. D., T. A. Merritt, M. Hallman, G. Heldt, R. J. LaPolla, K. Hoey, R. A. Houghten, and C. G. Cochrane. 1991. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr. Res. 29:460-465.
10. Cochrane, C. G., and S. D. Revak. 1994. Protein-phospholipid interactions in pulmonary surfactant. Chest 105:57S-62S.
11. Cochrane, C. G., and S. D. Revak. 1991. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 254:566-568.
12. Kobayashi, T., K. Nitta, R. Takahashi, K. Kurashima, B. Robertson, and Y. Suzuki. 1991. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. J. Appl. Physiol. 71:530-536.
13. Sarin, V. K., S. Gupta, T. K. Leung, V. E. Taylor, B. L. Ohning, J. A. Whitsett, and J. L. Fox. 1990. Biophysical and biological activity of a synthetic 8.7 kD hydrophobic pulmonary surfactant protein SP-B. Proc. Natl. Acad. Sci. U.S.A. 87:2633-2637.
14. 4-Surfactant by some serum components. Pediatr. Res. 35:324A. [#1929]
15. Amirkhanian, J. D., and T. A. Merritt. 1998. Inhibitory effects of oxyradicals on surfactant function: utilizing in vitro Fenton reaction. Lung 176:63-72.
16. 4 following surface area cycling and addition of fibrinogen. Lung 175:225-233.
17. Seeger, W., C. Grube, A. Gunther, and R. Schmidt. 1993. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur. Respir. J. 6:971-977.
18. 4-Surfactant in preterm infants with respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:404-410.
19. Cochrane, C. G., S. D. Revak, I. U. Schraufstatter, R. C. Hoch, and C. Henderson. 1997. Lavage with dilute surfactant in a model of acute respiratory distress syndrome (ARDS) (abstract). Am. J. Respir. Crit. Care Med. 155:A391.
20. 4-Surfactant in models of meconium aspiration syndrome. Pediatr Res. 44:705-715.
21. Balaraman, V., J. Meister, T. L. Ku, S. L. Sood, E. Tam, J. Killeen, C. F. T. Uyehara, E. Egan, and D. Easa. 1998. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Am. J. Respir. Crit. Care Med. 158:12-17.
22. Steinberg, K. P., D. R. Mitchell, R. J. Maunder, J. A. Milberg, M. E. Whitcomb, and L. D. Hudson. 1991. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148:556-561.
23. Willson, D. F., J. H. Hua, L. A. Bauman, A. Zaritsky, H. Crat, K. Dockery, D. Conrad, and H. Dalton. 1996. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit. Care Med. 24:1316-1322.
24. Anzueto, A., R. P. Baughman, K. K. Guntupalli, J. G. Weg, H. P. Wiedemann, A. A. Raventós, F. Lemaire, W. Long, D. S. Zaccardelli, and E. N. Pattishall. 1996. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N. Engl. J. Med. 334:1417-1421.
25. Gregory, T. J., K. P. Steinberg, R. Spragg, J. E. Gadek, T. M. Hyers, W. J. Longmore, M. A. Moxley, G.-Z. Cai, R. D. Hite, R. M. Smith, L. D. Hudson, C. Crim, P. Newton, B. R. Mitchell, and A. J. Gold. 1996. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:1309-1315.
26. Spragg, R. G., N. Gilliard, P. Richman, R. M. Smith, R. D. Hite, D. Pappert, B. Robertson, T. Curstedt, and D. Strayer. 1994. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105:195-202.
27. Walmrath, D., A. Günther, H. A. Ghofrani, R. Schermuly, T. Schneider, F. Grimminger, and W. Seeger. 1996. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am. J. Respir. Crit. Care Med. 154:57-62.
28. Baumgart, S. 1996. Extracorporeal membrane oxygenation. In A. R. Spitzer, editor. Intensive Care of the Fetus and Neonato. Mosby, St. Louis. 602-618.
29. Fort, P., C. Farmer, J. Westerman, J. Johannigman, W. Beninati, S. Dolan, and S. Derdak. High-frequency oscillatory ventilation for adult respiratory distress syndrome-a pilot study. Crit. Care Med. 25:937-947.
30. Matthay, M. A., J. F. Pittet, and C. Jayr. 1998. Just say NO to inhaled nitric oxide for the acute respiratory distress syndrome. Crit. Care Med. 26:1-2.
31. Slutsky, A. S., and L. N. Tremblay. 1998. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J. Respir. Crit. Care Med. 157:1721-1725.